What does Reata Pharmaceuticals, Inc. do?

Jun 22 2025 06:29 PM IST
share
Share Via
Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies that target mitochondrial function, oxidative stress, and inflammation, with a market cap of approximately USD 6.56 billion. As of June 2023, it reported net sales of USD 23 million and a net profit of USD 193 million.
Overview:
Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates that modulate regulatory proteins related to mitochondrial function, oxidative stress, and inflammation, addressing serious medical needs in the pharmaceuticals industry with a market cap of USD 6,556.92 Million.

Financial Snapshot:
Most recent Net Sales: 23 Million (Quarterly Results - Jun 2023)
Most recent Net Profit: 193 Million (Quarterly Results - Jun 2023)
Market cap: USD 6,556.92 Million

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.40
Return on Equity: -419.18%
Price to Book: 75.12

Contact Details:
Address: 5320 Legacy Dr, PLANO TX: 75024-3127
Tel: ['1 972 8652219', '1 855 551851201']
Fax: 1 302 6555049
Website: https://www.reatapharma.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News